CannabiSage™ provides evidence-rated guidance, education and information for adults 50 and over considering therapeutic cannabis — built around how aging changes the way medications and cannabis work in your body.
Where the evidence is solid, we say so. Where it’s mixed or limited, we say that too.
Slower metabolism, multiple medications, balance and cognitive considerations — content shaped by how age changes the conversation.
We name the medication classes that interact with cannabis — including blood thinners, antidepressants, statins, hormone therapies, and several cancer treatments — so you can raise them with your healthcare provider.
Plain-language answers to the questions many people 50+ have regarding the use of cannabis. Each article explores the implications and issues you should consider and discuss with your healthcare provider. The information in the articles is not intended to be medical advice.
Therapeutic Cannabis and the 50+ Adult: Evidence, Risks, Benefits, and Informed Choice.
Seventeen chapters distilling what’s known, what’s promising, and what’s still unsupported about cannabis use in older adults. Written for readers who want the actual evidence — not testimonials or marketing.
Ken Feldman brings four decades of decision-framework expertise. Nadine Laham brings a lifetime in education and a deeply personal understanding of aging. Together, they built CannabiSage™ for the family member, neighbor, or patient who deserves better than guesswork.
